Top

Current Cardiovascular Imaging Reports

Published in:

Open Access 01-01-2018 | Cardiac Magnetic Resonance (E Nagel and V Puntmann, Section Editors)

Characterizing Cardiac Involvement in Chronic Kidney Disease Using CMR—a Systematic Review

Authors: Kenneth Mangion, Kirsty McDowell, Patrick B. Mark, Elaine Rutherford

Published in: Current Cardiovascular Imaging Reports | Issue 1/2018

Abstract

Purpose of Review

The aim of the review was to identify and describe recent advances (over the last 3 years) in cardiac magnetic resonance (CMR) imaging in patients with chronic kidney disease (CKD). We conducted a literature review in line with current guidelines.

Recent Findings

The authors identified 22 studies. Patients with CKD had left ventricular global and regional dysfunction and adverse remodeling. Stress testing with CMR revealed a reduced stress-response in CKD patients. Native T1 relaxation times (as a surrogate markers of fibrosis) are elevated in CKD patients, proportional to disease duration. Patients with CKD have reduced strain magnitudes and reduced aortic distensibility.

Summary

CMR has diagnostic utility to identify and characterize cardiac involvement in this patient group. A number of papers have described novel findings over the last 3 years, suggesting that CMR has potential to become more widely used in studies in this patient group.

Glassock RJ, Warnock DG, Delanaye P. The global burden of chronic kidney disease: estimates, variability and pitfalls. Nat Rev Nephrol. 2017;13(2):104–14. https://doi.org/10.1038/nrneph.2016.163.CrossRefPubMed

Ene-Iordache B, Perico N, Bikbov B, Carminati S, Remuzzi A, Perna A, et al. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study. Lancet Glob Health. 2016;4(5):e307–19. https://doi.org/10.1016/S2214-109X(16)00071-1.

GBD 2013 Mortality and causes of death collaborators. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2015;385(9963):117–71.

Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJL, Mann JF, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet Lond Engl. 2013;382(9889):339–52. https://doi.org/10.1016/S0140-6736(13)60595-4.

U.S. Renal Data System. USRDS [Internet]. USRDS 2007 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2007. Available from: https://www.usrds.org/atlas07.aspx.

Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet Lond Engl. 2010;375(9731):2073–81.CrossRef

Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–305. https://doi.org/10.1056/NEJMoa041031.CrossRefPubMed

Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson. 2008;10(1):35. https://doi.org/10.1186/1532-429X-10-35.CrossRefPubMedPubMedCentral

Bellenger NG, Burgess MI, Ray SG, Lahiri A, Coats AJ, Cleland JG, et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Eur Heart J. 2000;21(16):1387–96. https://doi.org/10.1053/euhj.2000.2011.

10.

Grothues F, Smith GC, Moon JCC, Bellenger NG, Collins P, Klein HU, et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol. 2002;90(1):29–34. https://doi.org/10.1016/S0002-9149(02)02381-0.

11.

Stewart GA, Foster J, Cowan M, Rooney E, McDonagh T, Dargie HJ, et al. Echocardiography overestimates left ventricular mass in hemodialysis patients relative to magnetic resonance imaging. Kidney Int. 1999;56(6):2248–53. https://doi.org/10.1046/j.1523-1755.1999.00786.x.CrossRefPubMed

12.

Dill T. Contraindications to magnetic resonance imaging. Heart. 2008;94(7):943–8. https://doi.org/10.1136/hrt.2007.125039.CrossRefPubMed

13.

PRISMA [Internet]. [cited 2015 Oct 9]. Available from: http://www.prisma-statement.org/statement.htm.

14.

Rutherford E, JR W-MC, Patel RK, Houston JG, Roditi G, Struthers AD, et al. Research cardiac magnetic resonance imaging in end stage renal disease—incidence, significance and implications of unexpected incidental findings. Eur Radiol. 2017;27(1):315–24. https://doi.org/10.1007/s00330-016-4288-4.CrossRefPubMed

15.

Arnold R, Schwendinger D, Jung S, Pohl M, Jung B, Geiger J, et al. Left ventricular mass and systolic function in children with chronic kidney disease-comparing echocardiography with cardiac magnetic resonance imaging. Pediatr Nephrol Berl Ger. 2016;31(2):255–65. https://doi.org/10.1007/s00467-015-3198-z.

16.

•• Buchanan C, Mohammed A, Cox E, Köhler K, Canaud B, Taal MW, et al. Intradialytic cardiac magnetic resonance imaging to assess cardiovascular responses in a short-term trial of hemodiafiltration and hemodialysis. J Am Soc Nephrol. 2016;ASN.2016060686. Technically and logistically complex study investigating the intra-dialytic myocardial hemodynamic and biomechanical changes. Novel findings .

17.

Dundon BK, Torpey DK, Nelson AJ, Wong DTL, Duncan RF, Meredith IT, et al. Beneficial cardiovascular remodeling following arterio-venous fistula ligation post-renal transplantation: a longitudinal magnetic resonance imaging study. Clin Transpl. 2014;28(8):916–25. https://doi.org/10.1111/ctr.12402.

18.

Friesen T, Jassal DS, Zhu M, Eng F, Rigatto C, Tangri N, et al. Cardiovascular remodeling during long-term nocturnal home hemodialysis. Clin Exp Nephrol. 2015;19(3):514–20. https://doi.org/10.1007/s10157-014-0992-z.

19.

• Odudu A, Eldehni MT, McCann GP, CW MI. Randomized controlled trial of individualized dialysate cooling for cardiac protection in hemodialysis patients. Clin J Am Soc Nephrol CJASN. 2015;10(8):1408–17. Randomised control trial of CKD patients allocated to usual hemodialysis care versus cooled dialysis. Patients undergoing cooler HD experienced a regression in LV mass and had improved aortic distensibility. CrossRefPubMed

20.

Odudu A, Eldehni MT, McCann GP, Horsfield MA, Breidthardt T, McIntyre CW. Characterisation of cardiomyopathy by cardiac and aortic magnetic resonance in patients new to hemodialysis. Eur Radiol. 2016;26(8):2749–61. https://doi.org/10.1007/s00330-015-4096-2.CrossRefPubMed

21.

Patel RK, Pennington C, Stevens KK, Taylor A, Gillis K, Rutherford E, et al. Effect of left atrial and ventricular abnormalities on renal transplant recipient outcome—a single-center study. Transplant Res [Internet]. 2014 Dec 3 [cited 2017 Sep 25];3. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261520/.

22.

Ross BA, Wald R, Goldstein MB, Yuen DA, Leipsic J, Kiaii M, et al. Relationships between left ventricular structure and function according to cardiac MRI and cardiac biomarkers in end-stage renal disease. Can J Cardiol. 2017;33(4):501–7. https://doi.org/10.1016/j.cjca.2016.11.021.

23.

Sarak B, Wald R, Goldstein MB, Deva DP, Leipsic J, Kiaii M, et al. Relationship between changes in blood pressure and left ventricular mass over 1 year in end-stage renal disease. J Hypertens. 2017;35(8):1709–16. https://doi.org/10.1097/HJH.0000000000001353.

24.

Wald R, Goldstein MB, Wald RM, Harel Z, Kirpalani A, Perl J, et al. Correlates of left ventricular mass in chronic hemodialysis recipients. Int J Card Imaging. 2014;30(2):349–56. https://doi.org/10.1007/s10554-013-0337-0.

25.

Wald R, Goldstein MB, Perl J, Kiaii M, Yuen D, Wald RM, et al. The association between conversion to in-centre nocturnal hemodialysis and left ventricular mass regression in patients with end-stage renal disease. Can J Cardiol. 2016;32(3):369–77. https://doi.org/10.1016/j.cjca.2015.07.004.

26.

Parnham S, Gleadle JM, Leong D, Grover S, Bradbrook C, Woodman RJ, et al. Myocardial perfusion is impaired in asymptomatic renal and liver transplant recipients: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 2015;17(1):56. https://doi.org/10.1186/s12968-015-0166-5.

27.

Parnham S, Gleadle JM, Bangalore S, Grover S, Perry R, Woodman RJ, et al. Impaired myocardial oxygenation response to stress in patients with chronic kidney disease. J Am Heart Assoc Cardiovasc Cerebrovasc Dis [Internet]. 2015 Aug 10 [cited 2017 Sep 24];4(8). Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599475/.

28.

Ripley DP, Kannoly S, Gosling OE, Hossain E, Chawner RR, Moore J, et al. Safety and feasibility of dobutamine stress cardiac magnetic resonance for cardiovascular assessment prior to renal transplantation. J Cardiovasc Med Hagerstown Md. 2014;15(4):288–94. https://doi.org/10.2459/JCM.0000000000000029.

29.

• Edwards NC, Moody WE, Yuan M, Hayer MK, Ferro CJ, Townend JN, et al. Diffuse interstitial fibrosis and myocardial dysfunction in early chronic kidney disease. Am J Cardiol. 2015;115(9):1311–7. Advanced CMR imaging can identify changes in myocardial tissue in the earliest stages of chronic kidney disease. CrossRefPubMed

30.

Gimpel C, Jung BA, Jung S, Brado J, Schwendinger D, Burkhardt B, et al. Magnetic resonance tissue phase mapping demonstrates altered left ventricular diastolic function in children with chronic kidney disease. Pediatr Radiol. 2017;47(2):169–77. https://doi.org/10.1007/s00247-016-3741-5.

31.

• Graham-Brown MP, March DS, Churchward DR, Stensel DJ, Singh A, Arnold R, et al. Novel cardiac nuclear magnetic resonance method for noninvasive assessment of myocardial fibrosis in hemodialysis patients. Kidney Int. 2016;90(4):835–44. Advanced CMR imaging identifies myocardial tissue changes in chronic kidney disease patients with a longer mean hemodialysis vintage (21 months), compared with healthy volunteers. CrossRefPubMed

32.

Graham-Brown MPM, Rutherford E, Levelt E, March DS, Churchward DR, Stensel DJ, et al. Native T1 mapping: inter-study, inter-observer and inter-center reproducibility in hemodialysis patients. J Cardiovasc Magn Reson. 2017;19(1):21. https://doi.org/10.1186/s12968-017-0337-7.

33.

Holman R, Olynyk JK, Kulkarni H, Ferrari P. Characterization of hepatic and cardiac iron deposition during standard treatment of anaemia in haemodialysis. Nephrology. 2017;22(2):114–7. https://doi.org/10.1111/nep.12735.CrossRefPubMed

34.

• Rutherford E, Talle MA, Mangion K, Bell E, Rauhalammi SM, Roditi G, et al. Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mapping. Kidney Int [Internet]. [cited 2016 Sep 12]; Available from: http://www.sciencedirect.com/science/article/pii/S0085253816302988. Advanced CMR imaging identifies myocardial tissue changes in chronic kidney disease patients with a mean hemodialysis vintage of 6 months, compared with healthy volunteers.

35.

Tolouian R, Mulla ZD, Diaz J, Aguila J, Ramos-Duran L. Liver and cardiac iron deposition in patients on maintenance hemodialysis by magnetic resonance imaging T2. Iran J Kidney Dis. 2016;10(2):68–74.PubMed

36.

Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant. 1996;11(7):1277–85.CrossRefPubMed

37.

Stack AG, Saran R. Clinical correlates and mortality impact of left ventricular hypertrophy among new ESRD patients in the United States. Am J Kidney Dis. 2002;40(6):1202–10. https://doi.org/10.1053/ajkd.2002.36881.CrossRefPubMed

38.

Chand S, Chue CD, Edwards NC, Hodson J, Simmonds MJ, Hamilton A, et al. Endothelial nitric oxide synthase single nucleotide polymorphism and left ventricular function in early chronic kidney disease. PLoS ONE [Internet]. 2015 Jan 22 [cited 2017 Sep 24];10(1). Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303420/.

39.

Badve SV, Palmer SC, Strippoli GFM, Roberts MA, Teixeira-Pinto A, Boudville N, et al. The validity of left ventricular mass as a surrogate end point for all-cause and cardiovascular mortality outcomes in people with CKD: a systematic review and meta-analysis. Am J Kidney Dis. 2016;68(4):554–63. https://doi.org/10.1053/j.ajkd.2016.03.418.

40.

Schulz-Menger J, Bluemke DA, Bremerich J, Flamm SD, Fogel MA, Friedrich MG, et al. Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) Board of Trustees Task Force on Standardized Post Processing. J Cardiovasc Magn Reson. 2013;15(1):35. https://doi.org/10.1186/1532-429X-15-35.

41.

Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, et al. Effects of frequent hemodialysis on ventricular volumes and left ventricular remodeling. Clin J Am Soc Nephrol CJASN. 2013;8(12):2106–16. https://doi.org/10.2215/CJN.03280313.

42.

Collidge TA, Thomson PC, Mark PB, Traynor JP, Jardine AG, Morris STW, et al. Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort. Radiology. 2007;245(1):168–75. https://doi.org/10.1148/radiol.2451070353.

43.

Taylor AJ, Salerno M, Dharmakumar R, Jerosch-Herold M. T1 mapping: basic techniques and clinical applications. JACC Cardiovasc Imaging. 2016;9(1):67–81. https://doi.org/10.1016/j.jcmg.2015.11.005.CrossRefPubMed

44.

Puntmann VO, Peker E, Chandrashekhar Y, Nagel E. T1 mapping in characterizing myocardial disease. Circ Res. 2016;119(2):277–99. https://doi.org/10.1161/CIRCRESAHA.116.307974.CrossRefPubMed

45.

Kellman P, Hansen MS. T1-mapping in the heart: accuracy and precision. J Cardiovasc Magn Reson. 2014;16(1):2. https://doi.org/10.1186/1532-429X-16-2.CrossRefPubMedPubMedCentral

46.

Mangion K, Corcoran D, Carrick D, Berry C. New perspectives on the role of cardiac magnetic resonance imaging to evaluate myocardial salvage and myocardial hemorrhage after acute reperfused ST-elevation myocardial infarction. Expert Rev Cardiovasc Ther. 2016:1–12.

47.

Mark PB, Johnston N, Groenning BA, Foster JE, Blyth KG, Martin TN, et al. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney Int. 2006;69(10):1839–45. https://doi.org/10.1038/sj.ki.5000249.CrossRefPubMed

48.

Captur G, Gatehouse P, Kellman P, Heslinga FG, Keenan K, Bruehl R, et al. A T1 and ECV phantom for global T1 mapping quality assurance: the T1 mapping and ECV standardisation in CMR (T1MES) program. J Cardiovasc Magn Reson. 2016;18(1):W14. https://doi.org/10.1186/1532-429X-18-S1-W14.

49.

KDOQI, National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis. 2006;47(5 Suppl 3):S11–145.

50.

van Dijk P. Direct cardiac NMR imaging of heart wall and blood flow velocity. J Comput Assist Tomogr. 1984;8(3):429–36. https://doi.org/10.1097/00004728-198406000-00012.CrossRefPubMed

51.

Axel L, Dougherty LMR. Imaging of motion with spatial modulation of magnetization. Radiology. 1989;171(3):841–5. https://doi.org/10.1148/radiology.171.3.2717762.CrossRefPubMed

52.

Aletras AH, Ding S, Balaban RS, Wen H. DENSE: Displacement encoding with stimulated echoes in cardiac functional MRI. J Magn Reson. 1999;137(1):247–52. https://doi.org/10.1006/jmre.1998.1676.CrossRefPubMedPubMedCentral

53.

Zhong X, Spottiswoode BS, Meyer CH, Kramer CM, Epstein FH. Imaging three-dimensional myocardial mechanics using navigator-gated volumetric spiral cine DENSE MRI. Magn Reson Med. 2010;64(4):1089–97. https://doi.org/10.1002/mrm.22503.CrossRefPubMedPubMedCentral

54.

Hor KN, Baumann R, Pedrizzetti G, Tonti G, Gottliebson WM, Taylor M, et al. Magnetic resonance derived myocardial strain assessment using feature tracking. J Vis Exp. 2011;48:e2356–6.

55.

Mangion K, Gao H, McComb C, Carrick D, Clerfond G, Zhong X, et al. A novel method for estimating myocardial strain: assessment of deformation tracking against reference magnetic resonance methods in healthy volunteers. Sci Rep. 2016;6(1):38774. https://doi.org/10.1038/srep38774.

56.

Amundsen BH, Helle-Valle T, Edvardsen T, Torp H, Crosby J, Lyseggen E, et al. Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged magnetic resonance imaging. J Am Coll Cardiol. 2006;47(4):789–93. https://doi.org/10.1016/j.jacc.2005.10.040.

57.

Wu L, Germans T, Güçlü A, Heymans MW, Allaart CP, van Rossum AC. Feature tracking compared with tissue tagging measurements of segmental strain by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2014;16(1):10. https://doi.org/10.1186/1532-429X-16-10.CrossRefPubMedPubMedCentral

58.

Nandalur KR, Dwamena BA, Choudhri AF, Nandalur MR, Carlos RC. Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. J Am Coll Cardiol. 2007;50(14):1343–53. https://doi.org/10.1016/j.jacc.2007.06.030.CrossRefPubMed

59.

Nagel E, Klein C, Paetsch I, Hettwer S, Schnackenburg B, Wegscheider K, et al. Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation. 2003;108(4):432–7. https://doi.org/10.1161/01.CIR.0000080915.35024.A9.

60.

Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC, et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet Lond Engl. 2012;379(9814):453–60. https://doi.org/10.1016/S0140-6736(11)61335-4.

61.

Bauer WR, Nadler W, Bock M, Schad LR, Wacker C, Hartlep A, et al. The relationship between the BOLD-induced T2 and T 2*: a theoretical approach for the vasculature of myocardium. Magn Reson Med. 1999;42(6):1004–10. https://doi.org/10.1002/(SICI)1522-2594(199912)42:6<1004::AID-MRM2>3.0.CO;2-M.

62.

Edwards NC, Ferro CJ, Townend JN, Steeds RP. Aortic distensibility and arterial-ventricular coupling in early chronic kidney disease: a pattern resembling heart failure with preserved ejection fraction. Heart Br Card Soc. 2008;94(8):1038–43. https://doi.org/10.1136/hrt.2007.137539.CrossRef

63.

Wentland AL, Grist TM, Wieben O. Review of MRI-based measurements of pulse wave velocity: a biomarker of arterial stiffness. Cardiovasc Diagn Ther. 2014;4(2):193–206. https://doi.org/10.3978/j.issn.2223-3652.2014.03.04.PubMedPubMedCentral

64.

Chan PG, Smith MP, Hauser TH, Yeon SB, Appelbaum E, Rofsky NM, et al. Noncardiac pathology on clinical cardiac magnetic resonance imaging. JACC Cardiovasc Imaging. 2009;2(8):980–6. https://doi.org/10.1016/j.jcmg.2009.04.014.

Title: Characterizing Cardiac Involvement in Chronic Kidney Disease Using CMR—a Systematic Review
Authors: Kenneth Mangion
Kirsty McDowell
Patrick B. Mark
Elaine Rutherford
Publication date: 01-01-2018
Publisher: Springer US
Published in: Current Cardiovascular Imaging Reports / Issue 1/2018
Print ISSN: 1941-9066
Electronic ISSN: 1941-9074
DOI: https://doi.org/10.1007/s12410-018-9441-9

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Characterizing Cardiac Involvement in Chronic Kidney Disease Using CMR—a Systematic Review

Abstract

Purpose of Review

Recent Findings

Summary

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page